Cambridge's AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic
The company plans to initiate a Phase 2 clinical trial this year with AVR-RD-01 in Fabry disease. Source: BioSpace
Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016
Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace
Voyager Founder and CEO to Step Down, Hunt for New Leader Begins
Dr. Paul has been with the company for six years since its inception, initially as president of R&D, Source: BioSpace
Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital
The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace
3 FDA Decisions to Look Out for in February
Here is a look at a few important regulatory events scheduled for the month of February. Source: BioSpace
Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace
Despite Spike, Why Investors Should Still Avoid MannKind Like the Plague
MannKind could be sent to dilute shares in a significant manner, warns Maxim analyst Jason Kolbert in a research note released today. Source: BioSpace
SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs
Vical announced its restructuring late Tuesday. Source: BioSpace
3 Cases of Brain Damage Force the FDA to Slap a Hold on Bellicum's Lead Drug
The company is now waiting for the FDA to determine a path forward in resuming clinical studies. Source: BioSpace
Trump Endorses 'Right to Try' Experimental Drug Bill at State of the Union Address
The bill would allow access to experimental treatments for patients with terminal conditions. Source: BioSpace
- Go to the previous page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- …
- 288
- Go to the next page